![Young-Ho Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Young-Ho Lee
Corporate Officer/Principal at
Hanyang University
Profile
Young-Ho Lee is currently the Chief Executive Officer at Immunique Co. Ltd. and a Professor at Hanyang University.
In 2022-2023, he served as an Independent Director at NanoenTek, Inc. He holds a doctorate degree from Hanyang University.
Young-Ho Lee active positions
| Companies | Position | Start |
|---|---|---|
Hanyang University
 Hanyang University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Young-Ho Lee
| Companies | Position | End |
|---|---|---|
| NANOENTEK, INC. | Director/Board Member | 07/09/2023 |
Immunique Co. Ltd.
 Immunique Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a research and development company specializing in immune cell therapy | Chief Executive Officer | - |
Training of Young-Ho Lee
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
98
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
NanoenTek, Inc.
 NanoenTek, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes diagnostics & analytical equipment | Health Technology |
Hanyang University
Hanyang University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunique Co. Ltd.
Immunique Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a research and development company specializing in immune cell therapy | Health Technology |
- Stock Market
- Insiders
- Young-Ho Lee
